B. Braun Medical has expanded its product portfolio with the introduction of new Prontosan Wound Gel X.
It is the only wound gel available on the market that contains Betaine (surfactant) — a surface-active cleanser that provides immediate debridement (process of removing dead tissue from wounds) and Polyhexanide (PHMB) — which inhibits the growth of microorganisms within the product.
Prontosan Wound Gel X is used for maintaining a clean and moist wound environment that is conducive to healing.
"Prontosan Wound Gel X represents an important advancement in wound care infection prevention and is specifically designed to keep wounds clean," said Mike Kelly, Director of Marketing, Infection Control Products at B. Braun.
"It is indicated for the management of first and second-degree burns helping to put patients on the rapid road to recovery."
Prontosan Wound Gel X is an effective microbial barrier and it resists microbial colonization within the dressing. It also reduces microbial penetration through the dressing and softens necrotic tissue facilitating autolytic debridement.
In addition to the management of first and second-degree burns, Prontosan Wound Gel X is also indicated for ulcers (including diabetic foot, leg ulcers, and pressure ulcers), partial and full thickness wounds, large surface area wounds, and surgical incisions.
B. Braun Medical, a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry.